Anti-BLVRB/ BVRB/ FLR monoclonal antibody

Anti-BLVRB/ BVRB/ FLR antibody for FACS & in-vivo assay

Target products collectionGo to BLVRB/BLVRB products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP2025-Ab-1/ GM-Tg-hg-MP2025-Ab-2Anti-Human BLVRB monoclonal antibodyHuman
GM-Tg-rg-MP2025-Ab-1/ GM-Tg-rg-MP2025-Ab-2Anti-Rat BLVRB monoclonal antibodyRat
GM-Tg-mg-MP2025-Ab-1/ GM-Tg-mg-MP2025-Ab-2Anti-Mouse BLVRB monoclonal antibodyMouse
GM-Tg-cynog-MP2025-Ab-1/ GM-Tg-cynog-MP2025-Ab-2Anti-Cynomolgus/ Rhesus macaque BLVRB monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP2025-Ab-1/ GM-Tg-felg-MP2025-Ab-2Anti-Feline BLVRB monoclonal antibodyFeline
GM-Tg-cang-MP2025-Ab-1/ GM-Tg-cang-MP2025-Ab-2Anti-Canine BLVRB monoclonal antibodyCanine
GM-Tg-bovg-MP2025-Ab-1/ GM-Tg-bovg-MP2025-Ab-2Anti-Bovine BLVRB monoclonal antibodyBovine
GM-Tg-equg-MP2025-Ab-1/ GM-Tg-equg-MP2025-Ab-2Anti-Equine BLVRB monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP2025-Ab-1/ GM-Tg-hg-MP2025-Ab-2; GM-Tg-rg-MP2025-Ab-1/ GM-Tg-rg-MP2025-Ab-2;
GM-Tg-mg-MP2025-Ab-1/ GM-Tg-mg-MP2025-Ab-2; GM-Tg-cynog-MP2025-Ab-1/ GM-Tg-cynog-MP2025-Ab-2;
GM-Tg-felg-MP2025-Ab-1/ GM-Tg-felg-MP2025-Ab-2; GM-Tg-cang-MP2025-Ab-1/ GM-Tg-cang-MP2025-Ab-2;
GM-Tg-bovg-MP2025-Ab-1/ GM-Tg-bovg-MP2025-Ab-2; GM-Tg-equg-MP2025-Ab-1/ GM-Tg-equg-MP2025-Ab-2
Products NameAnti-BLVRB monoclonal antibody
Formatmab
Target NameBLVRB
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-BLVRB benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species BLVRB/ BVRB/ FLR VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLP003447human BLVRB Lentivirus plasmid
    ORF Viral VectorvGMLP003447human BLVRB Lentivirus particle
    ORF Viral VectorpGMLPm002820mouse Blvrb Lentivirus plasmid
    ORF Viral VectorvGMLPm002820mouse Blvrb Lentivirus particle


    Target information

    Target IDGM-MP2025
    Target NameBLVRB
    Gene ID645,233016,292737,703020,476456,101092315,281650,100068145
    Gene Symbol and SynonymsBLVRB,BVRB,FLR,HEL-S-10,SDR43U1
    Uniprot AccessionP30043,P52556
    Uniprot Entry NameBLVRB_HUMAN,BLVRB_BOVIN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseOvary Cancer
    Gene EnsemblENSG00000090013
    Target ClassificationN/A

    The target: BLVRB, gene name: BLVRB, also named as BVRB, FLR, HEL-S-10, SDR43U1. The final step in heme metabolism in mammals is catalyzed by the cytosolic biliverdin reductase enzymes A and B (EC 1.3.1.24).[supplied by OMIM, Jul 2009].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.